Current Drug Metabolism

Editor-in-Chief

Ming Hu
University of Houston College of Pharmacy
Houston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:21   Issue: 2
Pp: 77-78
Nigel J. Waters
DOI: 10.2174/138920022102200518073318



Potential of Mirabegron and its Extended-release Formulations for the Treatment of Overactive Bladder Syndrome

Volume:21   Issue: 2
Pp: 79-88
Pankaj Mandpe, Bala Prabhakar and Pravin Shende*
DOI: 10.2174/1389200221666200425211139




Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review

Volume:21   Issue: 2
Pp: 89-105
Muhammad Nasir Kalam , Muhammad Fawad Rasool , Asim Ur Rehman and Naveed Ahmed *
DOI: 10.2174/1389200221666200414094644




Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?

Volume:21   Issue: 2
Pp: 112-125
Francis Micheal*, Mohanlal Sayana, Rajendra Prasad and Balamurali Musuvathi Motilal
DOI: 10.2174/1389200221666200401105119




Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study

Volume:21   Issue: 2
Pp: 126-131
Bhuvanachandra Pasupuleti, Vamshikrishna Gone*, Ravali Baddam, Raj Kumar Venisetty and Om Prakash Prasad
DOI: 10.2174/1389200221666200218121050




Pharmacokinetics/Pharmacodynamics (PK/PD) of Ciprofloxacin in the Complicated Urinary Tract Infection (cUTI) Model in Diabetic Mice

Volume:21   Issue: 2
Pp: 132-139
Mahesh Kumar Reniguntla, Randhir Yedle, Ramesh Puttaswamy, Pradeep Puttarangappa , Somashekharayya Hiremath, Avinash Pawar, Mahesh Nanjundappa and Ramesh Jayaraman *
DOI: 10.2174/1389200221666200310105227




AOX1 and XDH Enzymes Genotyping and its Effect on Clinical Response to Azathioprine in Inflammatory Bowel Disease Patients Among Jordanian Population

Volume:21   Issue: 2
Pp: 140-144
Sereen Mahasneh, Ahmad Sharab, Mohammad Al Shhab, Mohammad Rashid and Malek Zihlif*
DOI: 10.2174/1389200221666200413125011




Further Considerations Towards an Effective and Efficient Oncology Drug Discovery DMPK Strategy

Volume:21   Issue: 2
Pp: 145-162
Beth Williamson , Nicola Colclough, Adrian John Fretland, Barry Christopher Jones, Rhys Dafydd Owen Jones and Dermot Francis McGinnity *
DOI: 10.2174/1389200221666200312104837